Essentialis, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 24
Rang # Quantité totale PI 61 429
Note d'activité PI 1,9/5.0    12
Rang # Activité PI 73 545

Brevets

Marques

15 0
5 0
4 0
0
 
Dernier brevet 2025 - Methods for treating subjects wi...
Premier brevet 2005 - Pharmaceutical formulations of p...

Derniers inventions, produits et services

2024 Invention Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome. Provided are...
Invention Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome. Provided are ...
2023 Invention Salts of potassium atp channel openers and uses thereof. Provided are immediate or prolonged adm...
2021 Invention Salts of potassium atp channel openers and uses thereof. ATP channels. Also provided are pharmace...
2019 Invention Pharmaceutical formulations of potassium atp channel openers and uses thereof. Provided are imme...
2018 Invention Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome. ATP channel o...
2015 Invention Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome. Provide...
2014 Invention Pharmaceutical formulations of potassium atp channel openers and uses thereof. ATP channel opener...
2013 Invention Salts of potassium atp channel openers and uses thereof. Provided are immediate or prolonged admi...
2006 Invention Salts of potassium atp channel openers and uses thereof. Provided are immediate or prolonge...
2005 Invention Pharmaceutical formulations of potassium atp channel openers and uses thereof. Provided are immed...
Invention Pharmaceutical formulations of potassium atp channel openers and uses thereof. Provided are...